Product Information
AMOXICILLIN 400 MG/5 ML SUSP is a generic product labeled by Sandoz Inc., priced at $0.0396 per ML under NDC 00781615757. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 26, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/5mL
Manufacturer
Sandoz Inc.NDC
00781615757
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLINApproval Type
Generic (ANDA)
FDA Application
ANDA065378FDA Approved
3/26/2007
TE Code
AB
On Market Since
3/26/2007
Pharmacological Classes
Price Statistics
The NADAC for AMOXICILLIN 400 MG/5 ML SUSP has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 37.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0396 per ML |
|---|---|
| All-time high | $0.0426 (Oct 15, 2025) |
| All-time low | $0.0214 (Sep 18, 2019) |
| 52-week high | $0.0426 |
| 52-week low | $0.0386 |
| Median price | $0.0273 |
| Average price | $0.0295 |
| Largest weekly change | +24.0% (Dec 20, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOXICILLIN 400 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AMOXICILLIN 400 MG/5 ML SUSP, manufactured by Sandoz Inc., is $0.0396 per ML (NDC 00781615757), effective Sep 30, 2026.
How has the price of AMOXICILLIN 400 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AMOXICILLIN 400 MG/5 ML SUSP has risen 37.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMOXICILLIN 400 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for AMOXICILLIN 400 MG/5 ML SUSP has ranged from a low of $0.0214 (Sep 18, 2019) to a high of $0.0426 (Oct 15, 2025), with a median of $0.0273 per ML.
Are there cheaper alternatives to AMOXICILLIN 400 MG/5 ML SUSP?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOXICILLIN 400 MG/5 ML SUSP, is $0.0338 per ML — about 15% below AMOXICILLIN 400 MG/5 ML SUSP.
Who manufactures AMOXICILLIN 400 MG/5 ML SUSP?
AMOXICILLIN 400 MG/5 ML SUSP (NDC 00781615757) is labeled by Sandoz Inc., and CMS classifies it as a generic product.